Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients

Table 3

Frequency of tissue infiltrating MDSC subsets in benign and malignant pancreatic tissue.

	PC	CP	P value
Lin-HLA-DR-	57.3 (9.4–90.9)*	91.82 (10.6–95.8)*	0.07
Lin-HLA-DR-CD33+11b+	2.9 (1.4–27.6)*	0.35 (0.03–13.7)*	0.48
Lin-HLA-DR-CD33+11b+CD15+	11.1 (0.5–72.3)*	0.2 (0–45.1)*	0.037
Lin-HLA-DR-CD14+	2.5 (0.19–5.07)*	0.3 (0.1–17.5)*	0.66
HLA-DR-/^lowCD14+	2.7 (0.5–5.1)*	2.3 (0–14.1)*	0.62
HLA-DR-/^LowCD33+	6.9 (0.82–25.5)*	11.5 (0.31–13.6)*	0.82

PC: pancreatic cancer; CP: chronic pancreatitis; HDs: healthy donors.∗Data shown represent median (range). The bold values refer to statistically significant 𝑃 values.